Illumina Newswire (Page 5)

Illumina Newswire (Page 5)

Comprehensive Real-Time News Feed for Illumina. (Page 5)

Results 81 - 100 of 1,044 in Illumina

  1. Illumina, Inc. (ILMN) Position Boosted by Norinchukin Bank TheRead the original story w/Photo

    May 23, 2017 | Daily Political

    Norinchukin Bank The increased its position in Illumina, Inc. by 6.7% during the first quarter, Holdings Channel reports. The fund owned 9,506 shares of the life sciences company's stock after buying an additional 595 shares during the period.

    Comment?

  2. Juno Appoints To Board Of DirectorsRead the original story

    May 22, 2017 | BioSpace

    Juno Therapeutics, Inc. , a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced it has appointed Jay Flatley to its Board of Directors. Mr. Flatley is Executive Chairman of Illumina, Inc. A successful entrepreneur, Mr. Flatley brings to Juno's board his considerable experience building a highly successful and innovative healthcare company.

    Comment?

  3. Illumina, Inc. (ILMN) Stake Decreased by Livforsakringsbolaget Skandia OmsesidigtRead the original story w/Photo

    May 23, 2017 | IntersportsWire

    Livforsakringsbolaget Skandia Omsesidigt cut its position in shares of Illumina, Inc. by 71.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,847 shares of the life sciences company's stock after selling 7,000 shares during the period.

    Comment?

  4. Illumina, Inc. (ILMN) Stock Rating Upgraded by Vetr Inc.Read the original story w/Photo

    May 22, 2017 | Daily Political

    ... reports on ILMN. Cantor Fitzgerald reiterated a "neutral" rating and issued a $155.00 target price on shares of Illumina in a research note on Wednesday, February 1st. Leerink Swann lifted their target price on shares of Illumina from $134.00 to ...

    Comment?

  5. Lyell Wealth Management LP Sells 70 Shares of Illumina, Inc.Read the original story w/Photo

    May 22, 2017 | IntersportsWire

    Lyell Wealth Management LP cut its position in shares of Illumina, Inc. by 1.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,459 shares of the life sciences company's stock after selling 70 shares during the period.

    Comment?

  6. Illumina, Inc. (ILMN) Receives Average Recommendation of "Hold" from AnalystsRead the original story w/Photo

    May 22, 2017 | AmericanBankingNews.com

    Shares of Illumina, Inc. have earned a consensus rating of "Hold" from the twenty-three brokerages that are presently covering the company. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company.

    Comment?

  7. Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader...Read the original story

    May 22, 2017 | PressReleasePoint

    May 22, 2017-- Illumina, Inc. announced today that Mark Van Oene has been named Chief Commercial Officer. Van Oene was previously Illumina's Senior Vice President of the Americas region and subsequently named interim Chief Commercial Officer in late 2016.

    Comment?

  8. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    May 22, 2017 | Business Wire

    ... addition to the RingCentral portfolio providing large-scale virtual meetings for audiences across global reg... )--Illumina, Inc. (NASDAQ: ILMN) announced today that Mark Van Oene has been named Chief Commercial Officer. Van Oene was previously ...

    Comment?

  9. Illumina, Inc. (ILMN) Raised to "Strong-Buy" at Vetr Inc.Read the original story w/Photo

    May 22, 2017 | Daily Political

    ... stock. ILMN has been the topic of a number of other research reports. Zacks Investment Research cut shares of Illumina from a buy rating to a hold rating in a report on Thursday, April 13th. Evercore ISI raised shares of Illumina from a hold rating ...

    Comment?

  10. LS Investment Advisors LLC Decreases Position in Illumina, Inc.Read the original story w/Photo

    May 21, 2017 | IntersportsWire

    LS Investment Advisors LLC lowered its stake in Illumina, Inc. by 1.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,243 shares of the life sciences company's stock after selling 37 shares during the period.

    Comment?

  11. Illumina (ILMN) Getting Positive Media Coverage, Analysis ShowsRead the original story w/Photo

    May 18, 2017 | IntersportsWire

    News stories about Illumina have been trending positive on Thursday, according to Alpha One Sentiment Analysis. The research group, a subsidiary of Accern, identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real-time.

    Comment?

  12. Exane Asset Management Acquires Shares of 8,500 Illumina, Inc.Read the original story w/Photo

    May 18, 2017 | Daily Political

    Exane Asset Management purchased a new stake in shares of Illumina, Inc. during the first quarter, Holdings Channel reports. The fund purchased 8,500 shares of the life sciences company's stock, valued at approximately $1,450,000.

    Comment?

  13. Illumina, Inc. (ILMN) Stake Boosted by Patriot Financial Group Insurance Agency LLCRead the original story w/Photo

    May 18, 2017 | IntersportsWire

    Patriot Financial Group Insurance Agency LLC raised its position in Illumina, Inc. by 3.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,083 shares of the life sciences company's stock after buying an additional 100 shares during the period.

    Comment?

  14. Advisors Asset Management Inc. Sells 7,693 Shares of Illumina, Inc.Read the original story w/Photo

    May 18, 2017 | Daily Political

    Advisors Asset Management Inc. reduced its stake in Illumina, Inc. by 47.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,397 shares of the life sciences company's stock after selling 7,693 shares during the period.

    Comment?

  15. Illumina, Inc. (ILMN) Upgraded to Strong-Buy by Vetr Inc.Read the original story w/Photo

    May 17, 2017 | AmericanBankingNews.com

    ... Jaffray Companies reissued an "overweight" rating and issued a $187.00 price target (up from $170.00) on shares of Illumina in a research note on Friday, April 14th. Zacks Investment Research raised shares of Illumina from a "hold" rating to a "buy" ...

    Comment?

  16. Illumina, Inc. (ILMN) Stake Decreased by Ameriprise Financial Inc.Read the original story w/Photo

    May 17, 2017 | Daily Political

    Ameriprise Financial Inc. decreased its stake in Illumina, Inc. by 5.8% during the first quarter, Holdings Channel reports. The firm owned 2,238,143 shares of the life sciences company's stock after selling 137,215 shares during the period.

    Comment?

  17. Somewhat Critical News Coverage Very Likely to Impact Illumina (ILMN) Share PriceRead the original story w/Photo

    May 17, 2017 | Daily Political

    News stories about Illumina have trended somewhat negative this week, according to AlphaOne. The research firm, a unit of Accern, scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time.

    Comment?

  18. Cantor Fitzgerald Raises Illumina, Inc. (ILMN) Price Target to $170.00Read the original story w/Photo

    May 17, 2017 | IntersportsWire

    ... life sciences company's stock. Other equities analysts have also issued reports about the company. Vetr upgraded Illumina from a buy rating to a strong-buy rating and set a $190.90 target price on the stock in a report on Tuesday, April 4th. Zacks ...

    Comment?

  19. Q4 2017 Earnings Forecast for Illumina, Inc. Issued By Leerink SwannRead the original story w/Photo

    May 17, 2017 | IntersportsWire

    Equities researchers at Leerink Swann boosted their Q4 2017 earnings per share estimates for Illumina in a report issued on Wednesday, according to Zacks Investment Research . Leerink Swann analyst P. Souda now forecasts that the life sciences company will post earnings per share of $1.27 for the quarter, up from their previous forecast of $1.09.

    Comment?

  20. Illumina, Inc. (ILMN) Rating Reiterated by Morgan StanleyRead the original story w/Photo

    May 15, 2017 | AmericanBankingNews.com

    ... Several other research analysts have also recently weighed in on the company. Zacks Investment Research raised Illumina from a "hold" rating to a "buy" rating and set a $191.00 target price for the company in a research note on Tuesday, April 4th. ...

    Comment?